Sector ratings Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 10:01:52 16/01/2026 pm IST			5-day change	1st Jan Change
115.60 ^CHF	+0.98%		+1.37%	+5.47%

16/01	Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren's Disease	CI
16/01	Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NOVARTIS AG	28TCr		AAA
ELI LILLY AND COMPANY	93TCr		A
JOHNSON & JOHNSON	53TCr		BBB
ABBVIE INC.	38TCr		AA
ROCHE HOLDING AG	37TCr		AA
ASTRAZENECA PLC	29TCr		A
MERCK & CO., INC.	27TCr		A
NOVO NORDISK A/S	27TCr		A
AMGEN INC.	18TCr		A
GILEAD SCIENCES, INC.	15TCr		AAA
PFIZER INC.	15TCr		BBB
SANOFI	11TCr		A
BRISTOL-MYERS SQUIBB COMPANY	11TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	11TCr		AA
GSK PLC	9.75TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	8.59TCr		AA
ALLERGAN PLC	6.37TCr	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.91TCr		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.07TCr		AA
BAYER AG	4.73TCr		AA
Average	22.67TCr		AA
Weighted average by Cap.			AA